Beijing Cost Of Revenue vs Net Income From Continuing Ops Analysis

603392 Stock

67.08 0.65 0.96%

Beijing Wantai financial indicator trend analysis is way more than just evaluating Beijing Wantai Biological prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Beijing Wantai Biological is a good investment. Please check the relationship between Beijing Wantai Cost Of Revenue and its Net Income From Continuing Ops accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Beijing Wantai Biological. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Cost Of Revenue vs Net Income From Continuing Ops

Cost Of Revenue vs Net Income From Continuing Ops Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Beijing Wantai Biological Cost Of Revenue account and Net Income From Continuing Ops. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Beijing Wantai's Cost Of Revenue and Net Income From Continuing Ops is 0.91. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Net Income From Continuing Ops in the same time period over historical financial statements of Beijing Wantai Biological, assuming nothing else is changed. The correlation between historical values of Beijing Wantai's Cost Of Revenue and Net Income From Continuing Ops is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Beijing Wantai Biological are associated (or correlated) with its Net Income From Continuing Ops. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income From Continuing Ops has no effect on the direction of Cost Of Revenue i.e., Beijing Wantai's Cost Of Revenue and Net Income From Continuing Ops go up and down completely randomly.

Correlation Coefficient

0.91

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Beijing Wantai Biological income statement and represents the costs associated with goods and services Beijing Wantai provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Net Income From Continuing Ops

Most indicators from Beijing Wantai's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Beijing Wantai Biological current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Beijing Wantai Biological. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Tax Provision is expected to grow to about 171.5 M, whereas Selling General Administrative is forecasted to decline to about 1.2 B.

	2022	2023	2024	2025 (projected)
Gross Profit	10.0B	4.7B	5.4B	3.4B
Total Revenue	11.2B	5.5B	6.3B	4.0B

Gross Profit Total Revenue

Beijing Wantai fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Net Receivables	Good Will	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Total Liab	Deferred Long Term Liab	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Long Term Debt	Common Stock Shares Outstanding
Total Assets		-0.47	0.88	1.0	-0.73	1.0	1.0	0.98	0.99	0.98	0.76	0.98	0.98	-0.68	0.98	0.75	0.99	0.91	0.88	0.97	1.0	0.89	0.88	0.98	0.06	0.86
Other Current Liab	-0.47		-0.13	-0.51	0.38	-0.5	-0.47	-0.63	-0.37	-0.6	-0.35	-0.48	-0.3	0.63	-0.54	-0.27	-0.48	-0.76	-0.13	-0.55	-0.41	-0.77	-0.32	-0.43	-0.09	-0.58
Total Current Liabilities	0.88	-0.13		0.86	-0.61	0.86	0.88	0.8	0.89	0.82	0.81	0.85	0.93	-0.3	0.81	0.78	0.88	0.68	1.0	0.78	0.9	0.63	0.96	0.9	0.01	0.83
Total Stockholder Equity	1.0	-0.51	0.86		-0.74	1.0	1.0	0.98	0.98	0.99	0.76	0.98	0.97	-0.69	0.99	0.74	0.99	0.93	0.86	0.98	0.99	0.91	0.87	0.98	0.07	0.87
Other Liab	-0.73	0.38	-0.61	-0.74		-0.74	-0.72	-0.73	-0.74	-0.72	-0.35	-0.67	-0.67	0.49	-0.8	-0.67	-0.64	-0.71	-0.62	-0.82	-0.73	-0.73	-0.68	-0.66	-0.55	-0.71
Net Tangible Assets	1.0	-0.5	0.86	1.0	-0.74		1.0	0.98	0.98	0.99	0.76	0.98	0.97	-0.68	0.99	0.75	0.99	0.92	0.87	0.98	0.99	0.9	0.88	0.98	0.07	0.87
Retained Earnings	1.0	-0.47	0.88	1.0	-0.72	1.0		0.98	0.99	0.98	0.77	0.98	0.98	-0.67	0.98	0.76	0.99	0.91	0.89	0.96	1.0	0.88	0.89	0.99	0.03	0.86
Accounts Payable	0.98	-0.63	0.8	0.98	-0.73	0.98	0.98		0.94	1.0	0.74	0.96	0.93	-0.75	0.97	0.74	0.98	0.97	0.8	0.96	0.96	0.95	0.84	0.97	0.05	0.87
Cash	0.99	-0.37	0.89	0.98	-0.74	0.98	0.99	0.94		0.94	0.73	0.96	0.98	-0.61	0.97	0.76	0.96	0.84	0.9	0.96	1.0	0.82	0.89	0.96	0.1	0.83
Non Current Assets Total	0.98	-0.6	0.82	0.99	-0.72	0.99	0.98	1.0	0.94		0.76	0.97	0.94	-0.74	0.97	0.72	0.98	0.97	0.82	0.96	0.97	0.95	0.85	0.97	0.04	0.87
Non Currrent Assets Other	0.76	-0.35	0.81	0.76	-0.35	0.76	0.77	0.74	0.73	0.76		0.82	0.77	-0.32	0.71	0.52	0.8	0.69	0.8	0.68	0.75	0.62	0.84	0.77	-0.15	0.82
Other Assets	0.98	-0.48	0.85	0.98	-0.67	0.98	0.98	0.96	0.96	0.97	0.82		0.96	-0.69	0.96	0.64	0.98	0.91	0.85	0.95	0.98	0.88	0.86	0.96	0.06	0.84
Net Receivables	0.98	-0.3	0.93	0.97	-0.67	0.97	0.98	0.93	0.98	0.94	0.77	0.96		-0.59	0.93	0.75	0.98	0.83	0.94	0.91	0.99	0.8	0.89	0.98	-0.02	0.81
Good Will	-0.68	0.63	-0.3	-0.69	0.49	-0.68	-0.67	-0.75	-0.61	-0.74	-0.32	-0.69	-0.59		-0.69	-0.36	-0.68	-0.79	-0.31	-0.7	-0.64	-0.82	-0.32	-0.66	-0.02	-0.42
Short Term Investments	0.98	-0.54	0.81	0.99	-0.8	0.99	0.98	0.97	0.97	0.97	0.71	0.96	0.93	-0.69		0.73	0.95	0.92	0.81	1.0	0.98	0.91	0.85	0.93	0.18	0.87
Non Current Liabilities Total	0.75	-0.27	0.78	0.74	-0.67	0.75	0.76	0.74	0.76	0.72	0.52	0.64	0.75	-0.36	0.73		0.75	0.64	0.79	0.71	0.76	0.6	0.78	0.77	0.08	0.73
Inventory	0.99	-0.48	0.88	0.99	-0.64	0.99	0.99	0.98	0.96	0.98	0.8	0.98	0.98	-0.68	0.95	0.75		0.91	0.88	0.93	0.98	0.88	0.87	1.0	-0.06	0.85
Other Current Assets	0.91	-0.76	0.68	0.93	-0.71	0.92	0.91	0.97	0.84	0.97	0.69	0.91	0.83	-0.79	0.92	0.64	0.91		0.68	0.91	0.88	0.99	0.75	0.9	0.11	0.85
Total Liab	0.88	-0.13	1.0	0.86	-0.62	0.87	0.89	0.8	0.9	0.82	0.8	0.85	0.94	-0.31	0.81	0.79	0.88	0.68		0.78	0.9	0.63	0.96	0.9	0.01	0.84
Deferred Long Term Liab	0.97	-0.55	0.78	0.98	-0.82	0.98	0.96	0.96	0.96	0.96	0.68	0.95	0.91	-0.7	1.0	0.71	0.93	0.91	0.78		0.96	0.91	0.83	0.91	0.24	0.85
Total Current Assets	1.0	-0.41	0.9	0.99	-0.73	0.99	1.0	0.96	1.0	0.97	0.75	0.98	0.99	-0.64	0.98	0.76	0.98	0.88	0.9	0.96		0.85	0.89	0.98	0.06	0.85
Intangible Assets	0.89	-0.77	0.63	0.91	-0.73	0.9	0.88	0.95	0.82	0.95	0.62	0.88	0.8	-0.82	0.91	0.6	0.88	0.99	0.63	0.91	0.85		0.71	0.86	0.19	0.82
Common Stock	0.88	-0.32	0.96	0.87	-0.68	0.88	0.89	0.84	0.89	0.85	0.84	0.86	0.89	-0.32	0.85	0.78	0.87	0.75	0.96	0.83	0.89	0.71		0.88	0.11	0.95
Property Plant Equipment	0.98	-0.43	0.9	0.98	-0.66	0.98	0.99	0.97	0.96	0.97	0.77	0.96	0.98	-0.66	0.93	0.77	1.0	0.9	0.9	0.91	0.98	0.86	0.88		-0.07	0.83
Long Term Debt	0.06	-0.09	0.01	0.07	-0.55	0.07	0.03	0.05	0.1	0.04	-0.15	0.06	-0.02	-0.02	0.18	0.08	-0.06	0.11	0.01	0.24	0.06	0.19	0.11	-0.07		0.19
Common Stock Shares Outstanding	0.86	-0.58	0.83	0.87	-0.71	0.87	0.86	0.87	0.83	0.87	0.82	0.84	0.81	-0.42	0.87	0.73	0.85	0.85	0.84	0.85	0.85	0.82	0.95	0.83	0.19

Click cells to compare fundamentals

Beijing Wantai Account Relationship Matchups

Beijing Wantai fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	3.5B	7.0B	16.2B	15.7B	18.1B	19.0B
Other Current Liab	203.3M	421.5M	480.6M	3.8M	3.4M	3.2M
Total Current Liabilities	829.0M	2.4B	3.5B	2.7B	3.1B	1.5B
Total Stockholder Equity	2.6B	4.5B	12.3B	12.7B	14.6B	15.3B
Other Liab	71.2M	94.3M	80.2M	58.5M	52.7M	59.9M
Net Tangible Assets	1.3B	2.3B	4.2B	12.0B	13.8B	14.5B
Retained Earnings	1.7B	3.4B	7.9B	7.6B	8.7B	9.1B
Accounts Payable	107.3M	154.1M	275.5M	389.6M	448.0M	470.4M
Cash	710.7M	1.4B	5.2B	3.8B	4.4B	4.6B
Non Current Assets Total	1.5B	2.4B	4.0B	5.4B	6.2B	6.5B
Non Currrent Assets Other	412.7M	299.1M	372.3M	459.4M	528.3M	266.7M
Other Assets	190.4M	297.0M	337.6M	602.9M	693.4M	728.1M
Net Receivables	691.3M	2.3B	3.9B	3.0B	3.4B	3.6B
Short Term Investments	50.4M	40.4M	2.0B	2.1B	2.4B	2.5B
Non Current Liabilities Total	94.3M	117.7M	179.4M	161.4M	185.6M	138.1M
Inventory	400.0M	593.2M	869.1M	905.5M	1.0B	1.1B
Other Current Assets	39.5M	105.2M	139.4M	495.1M	569.4M	597.9M
Total Liab	923.3M	2.5B	3.7B	2.8B	3.3B	1.7B
Deferred Long Term Liab	27.0M	27.8M	19.6M	164.6M	189.3M	198.8M
Total Current Assets	2.0B	4.6B	12.2B	10.3B	11.8B	12.4B
Intangible Assets	233.9M	295.1M	332.4M	642.7M	739.2M	776.1M
Property Plant Equipment	627.7M	791.0M	1.7B	2.2B	2.6B	2.7B
Net Invested Capital	2.6B	4.7B	12.6B	12.9B	14.8B	15.6B
Net Working Capital	1.1B	2.3B	8.7B	7.6B	8.8B	9.2B
Capital Stock	433.6M	607.0M	906.1M	1.3B	1.5B	732.4M
Property Plant And Equipment Net	791.0M	1.7B	2.2B	2.6B	3.0B	1.8B
Property Plant And Equipment Gross	1.1B	2.1B	2.8B	2.6B	3.0B	2.1B

Currently Active Assets on Macroaxis

CRM	Salesforce
C	Citigroup
GM	General Motors
WD	Walker Dunlop
MSFT	Microsoft

Other Information on Investing in Beijing Stock

Balance Sheet is a snapshot of the financial position of Beijing Wantai Biological at a specified time, usually calculated after every quarter, six months, or one year. Beijing Wantai Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Beijing Wantai and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Beijing currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Beijing Cost Of Revenue vs Net Income From Continuing Ops Analysis

Cost Of Revenue vs Net Income From Continuing Ops

Cost Of Revenue vs Net Income From Continuing Ops Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Net Income From Continuing Ops

Beijing Wantai fundamental ratios Correlations

Beijing Wantai Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Beijing Wantai fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Beijing Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Net Tangible Assets	+ 1.0	Total Assets
Retained Earnings	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Net Tangible Assets	+ 1.0	Total Stockholder Equity

Intangible Assets	- 0.82	Good Will
Deferred Long Term Liab	- 0.82	Other Liab
Short Term Investments	- 0.8	Other Liab
Other Current Assets	- 0.79	Good Will
Intangible Assets	- 0.77	Other Current Liab
Other Current Assets	- 0.76	Other Current Liab